US Stock MarketDetailed Quotes
PDSB PDS Biotechnology
- 3.200
- +0.010+0.31%
Close Nov 1 16:00 ET
- 3.190
- -0.010-0.31%
Post 16:57 ET
117.82MMarket Cap-2601P/E (TTM)
3.350High3.150Low250.90KVolume3.190Open3.190Pre Close824.62KTurnover0.71%Turnover RatioLossP/E (Static)36.82MShares6.85052wk High3.81P/B113.39MFloat Cap2.53052wk Low--Dividend TTM35.43MShs Float17.850Historical High--Div YieldTTM6.27%Amplitude0.615Historical Low3.286Avg Price1Lot Size
PDS Biotechnology Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -4.77%57.73M | 2.20%66.63M | -23.38%56.56M | -23.38%56.56M | -24.27%54.25M | 14.42%60.62M | 10.73%65.2M | 13.15%73.82M | 13.15%73.82M | 2.72%71.64M |
| -Cash and cash equivalents | -4.77%57.73M | 2.20%66.63M | -23.38%56.56M | -23.38%56.56M | -24.27%54.25M | 14.42%60.62M | 10.73%65.2M | 13.15%73.82M | 13.15%73.82M | 2.72%71.64M |
| Other current assets | -10.94%2.43M | -26.05%2.05M | -6.23%2.49M | -6.23%2.49M | -6.57%2.59M | -1.16%2.73M | 49.99%2.77M | 66.52%2.66M | 66.52%2.66M | 73.40%2.77M |
| Total current assets | -5.03%60.16M | 1.05%68.69M | -22.78%59.06M | -22.78%59.06M | -23.62%56.84M | 13.65%63.35M | 11.93%67.97M | 14.42%76.48M | 14.42%76.48M | 4.30%74.41M |
| Non current assets | ||||||||||
| Net PPE | -17.07%334.47K | -32.54%320.6K | -36.50%335.01K | -36.50%335.01K | -26.50%349.41K | 56.20%403.3K | 54.14%475.26K | 47.48%527.53K | 47.48%527.53K | 16.75%475.42K |
| -Gross PPE | -17.07%334.47K | -32.54%320.6K | -27.24%467.78K | -27.24%467.78K | -26.50%349.41K | 56.20%403.3K | 54.14%475.26K | 35.92%642.95K | 35.92%642.95K | 16.75%475.42K |
| -Accumulated depreciation | ---- | ---- | -15.04%-132.78K | -15.04%-132.78K | ---- | ---- | ---- | -0.07%-115.42K | -0.07%-115.42K | ---- |
| Total non current assets | -17.07%334.47K | -32.54%320.6K | -36.50%335.01K | -36.50%335.01K | -26.50%349.41K | 56.20%403.3K | 54.14%475.26K | 47.48%527.53K | 47.48%527.53K | 16.75%475.42K |
| Total assets | -5.11%60.5M | 0.81%69.01M | -22.88%59.39M | -22.88%59.39M | -23.63%57.19M | 13.85%63.75M | 12.14%68.45M | 14.60%77.01M | 14.60%77.01M | 4.37%74.89M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | -26.33%3.25M | 189.61%6M | 472.70%6.98M | 472.70%6.98M | 163.40%5.37M | 135.09%4.41M | -24.53%2.07M | -6.88%1.22M | -6.88%1.22M | 40.94%2.04M |
| -accounts payable | -26.33%3.25M | 189.61%6M | 472.70%6.98M | 472.70%6.98M | 163.40%5.37M | 135.09%4.41M | -24.53%2.07M | -6.88%1.22M | -6.88%1.22M | 40.94%2.04M |
| Current accrued expenses | -49.98%1.05M | 20.38%1.3M | -82.47%1.14M | -82.47%1.14M | 57.22%1.95M | 101.91%2.11M | -12.40%1.08M | 787.91%6.48M | 787.91%6.48M | 317.01%1.24M |
| Current debt and capital lease obligation | 9,173.33%10.48M | 3,591.21%7.35M | 1,365.92%4.22M | 1,365.92%4.22M | -85.47%54.54K | -66.28%112.96K | -36.05%199.09K | 11.25%288.04K | 11.25%288.04K | 80.65%375.25K |
| -Current debt | --10.42M | --7.29M | --4.17M | --4.17M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Current capital lease obligation | -48.30%58.4K | -71.33%57.08K | -80.63%55.79K | -80.63%55.79K | -85.47%54.54K | -66.28%112.96K | -36.05%199.09K | 11.25%288.04K | 11.25%288.04K | 80.65%375.25K |
| Current liabilities | 98.31%15.67M | 264.78%15.06M | 38.78%13.63M | 38.78%13.63M | 89.08%9.15M | 75.03%7.9M | -17.71%4.13M | 161.47%9.82M | 161.47%9.82M | 35.34%4.84M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | -40.60%13.9M | -28.10%16.76M | -15.34%19.63M | -15.34%19.63M | 2.45%23.55M | 39,138.68%23.41M | 15,758.03%23.31M | 9,918.09%23.18M | 9,918.09%23.18M | 7,221.19%22.99M |
| -Long term debt | -40.61%13.81M | -28.05%16.65M | -15.27%19.51M | -15.27%19.51M | 2.20%23.41M | --23.25M | --23.14M | --23.02M | --23.02M | --22.91M |
| -Long term capital lease obligation | -38.54%93.11K | -34.53%108.21K | -25.02%122.97K | -25.02%122.97K | 78.14%137.4K | 153.99%151.51K | 12.46%165.29K | -29.13%164.01K | -29.13%164.01K | -75.43%77.13K |
| Total non current liabilities | -40.60%13.9M | -28.10%16.76M | -15.34%19.63M | -15.34%19.63M | 2.45%23.55M | 39,138.68%23.41M | 15,758.03%23.31M | 9,918.09%23.18M | 9,918.09%23.18M | 7,221.19%22.99M |
| Total liabilities | -5.53%29.58M | 15.98%31.82M | 0.77%33.26M | 0.77%33.26M | 17.52%32.7M | 584.29%31.31M | 431.17%27.44M | 727.74%33.01M | 727.74%33.01M | 615.16%27.83M |
| Shareholders'equity | ||||||||||
| Share capital | 19.13%12.14K | 19.38%12.1K | 9.69%10.92K | 9.69%10.92K | 8.97%10.23K | 8.49%10.19K | 8.00%10.14K | 6.06%9.96K | 6.06%9.96K | 0.09%9.39K |
| -common stock | 19.13%12.14K | 19.38%12.1K | 9.69%10.92K | 9.69%10.92K | 8.97%10.23K | 8.49%10.19K | 8.00%10.14K | 6.06%9.96K | 6.06%9.96K | 0.09%9.39K |
| Retained earnings | -33.14%-163.43M | -39.46%-155.1M | -42.28%-144.5M | -42.28%-144.5M | -62.10%-133.6M | -63.68%-122.75M | -60.77%-111.22M | -67.30%-101.56M | -67.30%-101.56M | -51.55%-82.42M |
| Paid-in capital | 25.23%194.34M | 26.31%192.28M | 17.22%170.62M | 17.22%170.62M | 22.09%158.08M | 22.76%155.19M | 21.74%152.22M | 17.47%145.55M | 17.47%145.55M | 5.92%129.47M |
| Total stockholders'equity | -4.70%30.92M | -9.33%37.18M | -40.61%26.13M | -40.61%26.13M | -47.97%24.48M | -36.91%32.44M | -26.60%41.01M | -30.39%44M | -30.39%44M | -30.65%47.06M |
| Total equity | -4.70%30.92M | -9.33%37.18M | -40.61%26.13M | -40.61%26.13M | -47.97%24.48M | -36.91%32.44M | -26.60%41.01M | -30.39%44M | -30.39%44M | -30.65%47.06M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data